Advertisement
YOU ARE HERE: LAT HomeCollections

California and the West | IN BRIEF / HEALTHCARE

Inamed Management Is Told to Review Bid

November 17, 2005|From Associated Press

Cosmetic surgery product maker Inamed Corp. said its board of directors had instructed management to evaluate a proposed $3.2-billion cash-and-stock takeover bid from Botox maker Allergan Inc. that could trump a competing offer.

Santa Barbara-based Inamed, which makes breast implants and other cosmetic treatment products, had been in talks to be acquired by Medicis Pharmaceutical Corp. for $2.8 billion in cash and stock.

Inamed shares rose $1.51 to $82.79. Medicis shares rose 9 cents to $26.79, and shares of Allergan rose $1.75 to $98.

Advertisement
Los Angeles Times Articles
|
|
|